Herlyn M - Search Results

1

Herlyn M, Ferrone S, Ronai Z, Finerty J, Pelroy R, Mohla S. Herlyn M, et al. Cancer Res. 2001 Jun 1;61(11):4642-3. Cancer Res. 2001. PMID: 11389102 No abstract available.

2

New approaches to the biology of melanoma: a workshop of the National Institutes of Health Pathology B Study Section.

Herlyn M, Padarathsingh M, Chin L, Hendrix M, Becker D, Nelson M, DeClerck Y, McCarthy J, Mohla S. Herlyn M, et al. Am J Pathol. 2002 Nov;161(5):1949-57. doi: 10.1016/S0002-9440(10)64470-7. Am J Pathol. 2002. PMID: 12414540 Free PMC article. No abstract available.

3

ATF2 confers radiation resistance to human melanoma cells.

Ronai Z, Yang YM, Fuchs SY, Adler V, Sardana M, Herlyn M. Ronai Z, et al. Among authors: herlyn m. Oncogene. 1998 Jan 29;16(4):523-31. doi: 10.1038/sj.onc.1201566. Oncogene. 1998. PMID: 9484842

4

Contribution of phosphatidylinositol 3-kinase to radiation resistance in human melanoma cells.

Krasilnikov M, Adler V, Fuchs SY, Dong Z, Haimovitz-Friedman A, Herlyn M, Ronai Z. Krasilnikov M, et al. Among authors: herlyn m. Mol Carcinog. 1999 Jan;24(1):64-9. doi: 10.1002/(sici)1098-2744(199901)24:1<64::aid-mc9>3.0.co;2-2. Mol Carcinog. 1999. PMID: 10029412

5

Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.

Song JH, Song DK, Herlyn M, Petruk KC, Hao C. Song JH, et al. Among authors: herlyn m. Clin Cancer Res. 2003 Sep 15;9(11):4255-66. Clin Cancer Res. 2003. PMID: 14519653

6

Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions.

Moretti S, Pinzi C, Spallanzani A, Berti E, Chiarugi A, Mazzoli S, Fabiani M, Vallecchi C, Herlyn M. Moretti S, et al. Among authors: herlyn m. Int J Cancer. 1999 Apr 20;84(2):160-8. doi: 10.1002/(sici)1097-0215(19990420)84:2<160::aid-ijc12>3.0.co;2-r. Int J Cancer. 1999. PMID: 10096249

7

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA. Weber J, et al. Among authors: herlyn m. Cancer Res. 1994 Apr 1;54(7):1766-71. Cancer Res. 1994. PMID: 7511051

8

Mutation and expression of the p53 gene in malignant melanoma cell lines.

Weiss J, Schwechheimer K, Cavenee WK, Herlyn M, Arden KC. Weiss J, et al. Among authors: herlyn m. Int J Cancer. 1993 Jun 19;54(4):693-9. doi: 10.1002/ijc.2910540427. Int J Cancer. 1993. PMID: 8514460

9

Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues.

Andalib AR, Lawry J, Ali SA, Murray AK, Sisley K, Silcocks P, Herlyn M, Rees RC. Andalib AR, et al. Among authors: herlyn m. Melanoma Res. 1997 Feb;7(1):32-42. doi: 10.1097/00008390-199702000-00006. Melanoma Res. 1997. PMID: 9067963

10

Association of polymorphisms of FAS-1377, FAS-670, and FASL-844 genes with risk factors for cutaneous malignant melanoma.

Gaddipati H, Herlyn M. Gaddipati H, et al. Among authors: herlyn m. Cancer J. 2007 Jul-Aug;13(4):226-8. doi: 10.1097/PPO.0b013e31813fffdd. Cancer J. 2007. PMID: 17762755 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

681 results

Search Page

Filters